BI-3231 |
BI-3231 : Inhibitor of HSD17B13
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| HSD17B13 |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity within target family: hHSD17B11: IC50 > 10 µM (enzymatic assay).
Selectivity outside tar ...
Potency Cellular
In Vitro
HSD17B13
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.2c01884
In Vivo Validations
Mouse
Dose: 5 uM/Kg
Route of delivery:
Intravenous
Systemic clearance:
110 mL/min*Kg
Area Under the Curve::
153 nM*h
Volume of Distribution at Steady-State:
1.4 L/Kg
DOI Reference: 10.1021/acs.jmedchem.2c01884
Dose: 50 uM/Kg
Route of delivery:
Oral
Area Under the Curve::
16 uM*h
Bioavailability:
10%
DOI Reference: 10.1021/acs.jmedchem.2c01884
Dose: 80 uM/Kg
Route of delivery:
Subcutaneous
Area Under the Curve::
136 nM*h
Bioavailability:
89%
DOI Reference: 10.1021/acs.jmedchem.2c01884
Negative Control Compounds
BI-0955
Notes: BI-0955: Ki = > 10 µM (Enzymatic hHSD17B13 assay); IC50 > 10 µM (Cellular hHSD17B13 assay); Eurofins Safety screen (44 targets): PTGS2 (COX2) (44% ctrl), HTR2B (45 % ctrl)
SMILES:
CCN1C(C(C)=CN(Cc2nnc(c3ccc(c(c3F)OC)F)s2)C1=O)=O
Chemical Information
| Molecular Formula | C16H14F2N4O3S |
| SMILEs | CCn1c(=O)c(C)cn(Cc2nnc(-c3ccc(F)c(O)c3F)s2)c1=O |
| InChI | InChI=1S/C16H14F2N4O3S/c1-3-22-15(24)8(2)6-21(16(22)25)7-11-19-20-14(26-11)9-4-5-10(17)13(23)12(9)18/h4-6,23H,3,7H2,1-2H3 |
| Molecular weight | 380.08 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 40 |